MOBILion Systems is enabling advancements in disease diagnosis and treatment by commercializing instruments that improve multi-omics disease, drug, and biomarker discovery. Enhancing the study of the complement to genomics provides a better understanding of disease and drug target mechanisms and paves the way for earlier disease detection, more accurate diagnostics, improved treatment options for individual patients, and reduced healthcare costs.
MOBILion’s instruments provide unprecedented speed, sensitivity and resolution, allowing rapid detection of clinically relevant molecules such as proteins, peptides, metabolites, lipids, etc., to better predict, diagnose and treat disease. MOBILion’s instruments process population scale samples in days vs. years, and detect low abundance molecules never before seen with existing instrumentation, providing researchers and clinicians with increased confidence in clinical results.
Executive Leadership
All Members
HR & Accounts
Sales & Marketing
IT Support
Melissa Sherman, PhD
Chief Executive Officer
Melissa has a successful track record of building and advancing early stage businesses that are based
Craig Carra
Chief Financial Officer
Craig has over 20 years’ experience in the life sciences industry working in multiple executive level
Frederick Strathmann, PhD, MBA, DABCC (CC, TC)
SVP, US Business
Fred has over 10 years of experience in laboratory medicine, and has held various positions including
Puneet Suri
SVP, Digital & Software Strategy
In his role as SVP, Digital & Software Strategy, Puneet’s primary responsibility is to complete an
Team
All Members
HR & Accounts
Sales & Marketing
IT Support
Ed Cywinski
Senior Director of Finance
Daniel DeBord, PHD
Vice President of R&D
Daniel brings over 15 years of experience in instrumentation development, with a particular focus on ion
Greg Kilby, PHD
Senior Director of Applications & Market Development
Greg has over 20 years of experience in Separations and Mass Spectrometry analysis of biomolecules including
Jennifer Krone, PHD
Director of Strategic Partnerships
Jen has close to 30 years of experience in the field of mass spectrometry. She has
Brett Peterson
Director of North American Sales
Brett has over 15 years of experience in the LC/MS industry. Originally a bioanalytical scientist in
Paul Sakach
Service Manager
Paul’s focus throughout his four decade career has been exclusively in analytical instrumentation. He has worked
Katie Spruance
Senior Director of Talent & Culture
As a founding member of MOBILion, Katie has played a crucial role in building and nurturing
Darren Stivale
Senior Director of Operations
Darren brings over 25 years of operations leadership experience spanning multiple industries including defense and aerospace,
Gregory Webster
Vice President of Product Development
Greg manages the product development strategy and guides MOBILion through the development process. Greg has 10
Advisory Board
All Members
HR & Accounts
Sales & Marketing
IT Support
Kevin Bateman, PhD
Kevin is a Scientific Associate Vice President at Merck Research Laboratories in the Department of Pharmacokinetics, Pharmacodynamics, and Drug Metabolism (PPDM). Currently he is the
Sally Curley
Sally is Founder and CEO of Curley Global IR, LLC, an Investor Relations, Environmental-Social-Governance Survey and Corporate Governance strategic advisory firm. With more than 30
Tim Germann
Tim is the Chief Commercial Officer at Carterra. He’s spent the last 31 years commercializing technology in the life sciences and healthcare. For the last
Kaveh Kahen, PhD
Dr. Kaveh Kahen is currently the CEO of the Advion group. For nearly three decades, Advion has been focused on delivering customer-focused life science solutions
John McLean, PhD
John A. McLean is Stevenson Professor of Chemistry, Chair of the Department of Chemistry, Chair of the Faculty Senate, and Director of the Center for
Gustavo Salem
Mr. Salem is Co-Founder and Managing Partner at Eureka Life Science LLC, a management consulting firm focused on value creation for life science and diagnostics
Ravinder Singh, PhD
Ravinder is the director of the Mayo Clinic Endocrine Laboratory. He has a focused area of investigation that has broad applicability to the field. Dr.
David Speicher, PhD
David received his Ph.D. in Biochemistry from Pennsylvania State University, followed by postdoctoral training at Yale Medical School. He is currently the Caspar Wistar Professor
Board of Directors
All Members
HR & Accounts
Sales & Marketing
IT Support
Jenn Buechel
Jenn brings over 20 years of experience in launching products in a wide variety of industries, with a particular focus on bringing novel healthcare technologies from R&D to market. Jenn
Heiner Dreismann, PhD
Chairman
Heiner is a seasoned executive with more than 35 years of experience in the life sciences and health care industries and is regarded as a pioneer in the early adoption
Melissa Sherman, PhD
Chief Executive Officer
Melissa has a successful track record of building and advancing early stage businesses that are based on high value, breakthrough science in the regulated medical products sector. Melissa will lead
Jason Smith, PhD
Jason currently oversees the Life Sciences sector in North America for the IP Group. He has extensive experience developing and commercializing healthcare technology in large private and small start-up environments.
Todd Sone
Todd is a Partner at aMoon and has over 20 years of healthcare investment experience. Todd serves on the boards of Ayala Pharmaceuticals (AYLA), Biolojic Design, Theranica, and Smart Medical
Tad Weems
Tad is Managing Director of Agilent’s Early Stage Partnership team that manages the partnership/investment relationships of over 30 early stage life science tools companies. He has been in the life